Patent: 8,679,767

Summary for Patent: 8,679,767

Title:	Multiple reaction monitoring LC-MS/MS method to detect therapeutic antibodies in animal samples using framework signature peptides
Abstract:	Methods are disclosed to detect, characterize, measure, and quantitate human and humanized antibodies, and their conjugates, present in pre-clinical animal biological samples, including plasma/serum and tissue samples.
Inventor(s):	Kaur; Surinder (Lafayette, CA), Saad; Ola (Walnut Creek, CA), Xu; Keyang (Belmont, CA)
Assignee:	Genentech, Inc. (South San Francisco, CA)
Application Number:	13/469,332
Patent Claims:	see list of patent claims

Details for Patent 8,679,767

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Genentech, Inc.	RITUXAN	rituximab	Injection	103705	11/26/1997		2039-02-26
Idec Pharmaceuticals Corp.	RITUXAN	rituximab	Injection	103737	02/19/2002		2039-02-26
Genentech, Inc.	HERCEPTIN	trastuzumab	For Injection	103792	09/25/1998		2039-02-26
Genentech, Inc.	HERCEPTIN	trastuzumab	For Injection	103792	02/10/2017		2039-02-26
Genentech, Inc.	PERJETA	pertuzumab	Injection	125409	06/08/2012		2039-02-26
Genentech, Inc.	OCREVUS	ocrelizumab	Injection	761053	03/28/2017		2039-02-26
Genentech, Inc.	RITUXAN HYCELA	rituximab and hyaluronidase human	Injection	761064	06/22/2017		2039-02-26